Oragenics (OGEN) Profit After Tax (2010 - 2026)

Oragenics (OGEN) has 17 years of Profit After Tax data on file, last reported at -$2.2 million in Q1 2026.

• Quarterly Profit After Tax rose 0.77% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.8 million (up 4.92% YoY) and the FY2025 annual result came in at -$9.8 million, up 6.86% from the prior year.
• Profit After Tax improved to -$2.2 million in Q1 2026, from -$2.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.0 million in Q3 2023 to a low of -$12.7 million in Q4 2023.
• A 5-year average of -$3.4 million and a median of -$2.5 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax sank 469.66% — and 2024, when it jumped 73.73%.
• Tracing OGEN's Profit After Tax over 5 years: stood at -$2.2 million in 2022, then slumped by 469.66% to -$12.7 million in 2023, then jumped by 73.73% to -$3.3 million in 2024, then surged by 31.72% to -$2.3 million in 2025, then increased by 3.8% to -$2.2 million in 2026.
• The last three Profit After Tax figures came in at -$2.2 million (Q1 2026), -$2.3 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.